Alterity Therapeutics logo

Alterity Therapeutics Share Price (NASDAQ: ATHE)

$4.99

-0.11

(-2.16%)

Live

Last updated on

Check the interactive Alterity Therapeutics Stock chart to analyse performance

Alterity Therapeutics stock performance

as on August 23, 2025 at 12:26 AM IST

  • Today's Low:$4.99
    Today's High:$5.09

    Day's Volatility :1.96%

  • 52 Weeks Low:$1.00
    52 Weeks High:$7.00

    52 Weeks Volatility :85.7%

Alterity Therapeutics Stock Returns

PeriodAlterity Therapeutics LtdIndex (Russel 2000)
3 Months
17.65%
0.0%
6 Months
22.55%
0.0%
1 Year
278.79%
0.0%
3 Years
-16.65%
-7.7%

Alterity Therapeutics Ltd Key Stats

Check Alterity Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$5.1
Open
$5.0
Today's High
$5.13
Today's Low
$5.05
Market Capitalization
$77.2M
Today's Volume
$8.0K
52 Week High
$7.0
52 Week Low
$1.001
Revenue TTM
$3.7M
EBITDA
$-20.5M
Earnings Per Share (EPS)
$-2.26
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-155.77%

Stock Returns calculator for Alterity Therapeutics Stock including INR - Dollar returns

The Alterity Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Alterity Therapeutics investment value today

Current value as on today

₹3,82,311

Returns

₹2,82,311

(+282.31%)

Returns from Alterity Therapeutics Stock

₹2,78,030 (+278.03%)

Dollar Returns*

₹4,281 (+4.28%)

Indian investors sentiment towards Alterity Therapeutics Stock

43%

Period: Jul 22, 2025 to Aug 21, 2025. Change in 30 Days versus previous period

Search interest for Alterity Therapeutics Stock from India on INDmoney has increased by 43% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Alterity Therapeutics Ltd

  • Name

    Holdings %

  • Point72 Asset Management, L.P.

    0.89%

  • Morgan Stanley - Brokerage Accounts

    0.30%

  • Greenleaf Trust

    0.11%

  • UBS Group AG

    0.09%

  • BNP Paribas Arbitrage, SA

    0.06%

  • Twin Lakes Capital Management, LLC

    0.04%

Analyst Recommendation on Alterity Therapeutics Stock

Rating
Trend

Alterity Therapeutics Share Price Target

What analysts predicted

Upside of 120.44%

Target:

$11.00

Current:

$4.99

Alterity Therapeutics share price target is $11.00, a slight Upside of 120.44% compared to current price of $4.99 as per analysts' prediction.

Alterity Therapeutics Stock Insights

  • Price Movement

    In the last 1 year, ATHE stock has moved up by 278.8%
  • Decreasing Revenue

    Revenue is down for the last 3 quarters, 2.11M → 802.96K (in $), with an average decrease of 31.1% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 3 quarters, -12.61M → -3.58M (in $), with an average increase of 125.9% per quarter
  • ATHE vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 114.2% return, outperforming this stock by 129.5%

Alterity Therapeutics Ltd Financials

Revenue
Profit
Cash Flow
Annually
Quarterly
FY19
FY20
FY21
FY22
FY23
FY24
FY24Y/Y Change
Revenue
$2.7M
↑ 2.63%
Net Income
$-12.7M
↑ 38.51%
Net Profit Margin
-475.79%
↓ 123.25%

Alterity Therapeutics Technicals Summary

Sell

Neutral

Buy

Alterity Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Alterity Therapeutics Ltd Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Alterity Therapeutics Ltd logo
0.14%
22.55%
278.79%
-16.65%
-79.76%
Regeneron Pharmaceuticals, Inc. logo
4.5%
-14.59%
-49.64%
-0.73%
0.56%
Beone Medicines Ltd logo
6.48%
22.93%
60.47%
81.44%
32.24%
Vertex Pharmaceuticals Incorporated logo
-16.69%
-17.94%
-17.2%
38.81%
48.58%
Alnylam Pharmaceuticals, Inc. logo
43.34%
86.27%
68.31%
115.22%
254.29%

About Alterity Therapeutics Ltd

Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer's disease, Huntington disease, Parkinson's disease, and other neurological disorders in Australia. The company's lead drug candidate is ATH434, a small molecule drug candidate that has completed Phase I clinical trial for the treatment of Parkinson's disease. It is also developing ATH434-201, which is in Phase II clinical trial to treat multiple system atrophy early stage; ATH434-202 that is in Phase II clinical trial to treat multiple system atrophy; and PBT2 that has completed Phase 2a clinical trial to treat Alzheimer's disease. The company was formerly known as Prana Biotechnology Limited and changed its name to Alterity Therapeutics Limited in April 2019. Alterity Therapeutics Limited was incorporated in 1997 and is headquartered in Melbourne, Australia.
Organization
Alterity Therapeutics
Employees
10
CEO
Dr. David A. Stamler M.D.
Industry
Biotechnology

Key Management of Alterity Therapeutics Ltd

NameTitle
Mr. Geoffrey Paul Kempler B.Sc.
Co-Founder & Non-Executive Chairman
Dr. David A. Stamler M.D.
Chief Executive Officer
Ms. Abby Macnish Niven B.Com., B.Sc., C.F.A.
CFO & Company Secretary
Dr. Rudolph Emile Tanzi Ph.D.
Chief Scientific Advisor and Member of Research & Development Advisory Board
Dr. Steven D. Targum M.D.
Chief Medical Advisor
Dr. Robert Cherny
Head of Research

Important FAQs about investing in ATHE Stock from India :

What is Alterity Therapeutics share price today?

Alterity Therapeutics share price today is $4.99 as on . Alterity Therapeutics share today touched a day high of $5.09 and a low of $4.99.

What is the 52 week high and 52 week low for Alterity Therapeutics share?

Alterity Therapeutics share touched a 52 week high of $7.00 and a 52 week low of $1.00. Alterity Therapeutics stock price today i.e. is trending at $4.99, lower by 28.71% versus the 52 week high.

How to invest in Alterity Therapeutics Stock (ATHE) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Alterity Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Alterity Therapeutics Shares that will get you 0.3006 shares as per Alterity Therapeutics share price of $4.99 per share as on August 23, 2025 at 12:26 AM IST.

What is the minimum amount required to buy Alterity Therapeutics Stock (ATHE) from India?

Indian investors can start investing in Alterity Therapeutics (ATHE) shares with as little as ₹87.521 or $1 (as of August 22, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹875.21 in Alterity Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 22, 2025). Based on Alterity Therapeutics share’s latest price of $4.99 as on August 23, 2025 at 12:26 AM IST, you will get 2.0040 shares of Alterity Therapeutics. Learn more about fractional shares .

What are the returns that Alterity Therapeutics has given to Indian investors in the last 5 years?

Alterity Therapeutics stock has given -79.76% share price returns and 18.0% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your US Stock Investments?